Cash · 2018–2025

Keros Therapeutics cash

$287M−48.7% · FY2025

Keros Therapeutics (KROS) reported $287M in cash for fiscal 2025, −48.7% year on year.

$23.4M2018$7.0M2019$266M2020$230M2021$279M2022$331M2023$560M2024$287M2025
Keros Therapeutics — Cash, 2018–2025
Fiscal yearCashChangeFiling
FY20252025-12-31$287M−48.7%Open →
FY20242024-12-31$560M+69.1%Open →
FY20232023-12-31$331M+18.7%Open →
FY20222022-12-31$279M+21.3%Open →
FY20212021-12-31$230M−13.5%Open →
FY20202020-12-31$266M+3,687.4%Open →
FY20192019-12-31$7.0M−70.0%Open →
FY20182018-12-31$23.4M—Open →

Cash — Cash and cash equivalents is money available immediately at the balance-sheet date. It excludes short-term investments, which many large companies hold far more of.

Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2018–2025 compound annual growth +43.1%

Cash at companies of similar size

Full ranking by cash →

Cite this page

Ready-made references for the figures on this page, as published on September 25, 2026.

Wikipedia

{{cite web |title=Keros Therapeutics cash |url=https://companiesranked.com/en/company/keros-therapeutics/cash-on-hand |website=CompaniesRanked |date=2026-09-25 |language=en}}

APA 7

CompaniesRanked. (September 25, 2026). Keros Therapeutics cash. CompaniesRanked. https://companiesranked.com/en/company/keros-therapeutics/cash-on-hand

BibTeX

@misc{companiesranked-en-company-keros-therapeutics-cash-on-hand-2026,
  author       = {{CompaniesRanked}},
  title        = {{Keros Therapeutics cash}},
  year         = {2026},
  howpublished = {\url{https://companiesranked.com/en/company/keros-therapeutics/cash-on-hand}},
  note         = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
  urldate      = {2026-09-25}
}

The filing itself

The numbers above are read from this document: 10-Q · 0001664710-26-000049 · August 3, 2026

{{cite web |title=Keros Therapeutics cash — 10-Q (0001664710-26-000049) |url=https://www.sec.gov/Archives/edgar/data/1664710/000166471026000049/kros-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-08-03}}

The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.

← Keros Therapeutics overview